Turnstone Biologics
2015
FOUNDED
PRIVATE
STATUS
61-70
EMPLOYEES
Corporate
LATEST DEAL TYPE
$120M
LATEST DEAL AMOUNT
9
INVESTORS
Description
Developer of viral immunotherapies designed to improve survival for patients with cancer. The company's immunotherapies combine a bio-selected and engineered oncolytic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 12 York Street
- 3rd Floor
- Ottawa, Ontario K1S 3V5
- Canada
+1 (613) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Turnstone Biologics’s full profile, request a free trial.
Turnstone Biologics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Corporate | 19-Dec-2019 | $120M | 00000 | Completed | Pre-Clinical Trials | |
| 4. Later Stage VC (Series C) | 04-Jan-2019 | 0000 | 000.00 | Completed | Pre-Clinical Trials | |
| 3. Early Stage VC (Series B) | 02-Nov-2016 | 000.00 | 000.00 | Completed | Pre-Clinical Trials | |
| 2. Early Stage VC (Series A) | 28-Oct-2015 | $11.3M | $11.3M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 04-May-2015 | Completed | Pre-Clinical Trials |
Turnstone Biologics Competitors (27)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNAtrix | Venture Capital-Backed | Houston, TX | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 | Corporate Backed or Acquired | Seal Beach, CA | 000 | 00.000 | 000000&0 | |
| 000000 | Angel-Backed | Lyon, France | 00 | 00.000 | 0000000000 | 00.000 |
| 0000000 | Formerly VC-backed | London, United Kingdom | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 0000000000 0 | 00000 |
Turnstone Biologics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company | Corporation | Minority | 000 0000 | 000000 0 | ||
| Brace Pharma Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Eight Roads | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Sectoral Asset Management | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| F-Prime Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Turnstone Biologics Executive Team (11)
1 Former Executive
You’re viewing 5 of 11 executives. Get the full list »Turnstone Biologics Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ben Auspitz | F-Prime Capital Partners | Board Member | 000 0000 | |
| Bradley Bolzon Ph.D | Versant Venture Management | Board Member | 000 0000 | |
| Jeff Courtney | Fight Against Cancer Innovation Trust | Board Member | 000 0000 | |
| Jerel Davis Ph.D | Versant Venture Management | Board Member | 000 0000 | |
| Patrick Machado JD | Self | Board Member | 000 0000 |